TrialPath
← Back to searchRecruiting

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

NCT04491292 · M.D. Anderson Cancer Center
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Psychosocial Impact of COVID-19 Pandemic on MD Anderson Workforce
About this study
PRIMARY OBJECTIVE: I. To assess psychosocial and stress-related outcomes in employees at MD Anderson Cancer Center during and post the COVID-19 pandemic. SECONDARY OBJECTIVE: I. To identify demographic and occupational factors associated with COVID-19 related psychosocial and stress outcomes. OUTLINE: Participants complete 2 online questionnaires over 10 minutes each at baseline and at 3 months after the pandemic ends.
Eligibility criteria
Inclusion Criteria: * MD Anderson employees
Study design
Enrollment target: 20000 participants
Age groups: adult, older_adult
Timeline
Starts: 2020-05-18
Estimated completion: 2026-04-30
Last updated: 2026-01-28
Interventions
Other: Questionnaire Administration
Primary outcomes
  • Change in psychosocial outcomes (Baseline up to 3 months after the outbreak ends)
  • Change in stress-related outcomes (Baseline up to 3 months after the outbreak ends)
Sponsor
M.D. Anderson Cancer Center · other
With: National Cancer Institute (NCI)
Contacts & investigators
ContactPriya R. Bhosale · contact · priya.bhosale@mdanderson.org · 713-792-0221
InvestigatorPriya R Bhosale · principal_investigator, M.D. Anderson Cancer Center
All locations (1)
M D Anderson Cancer CenterRecruiting
Houston, Texas, United States
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce · TrialPath